November 6–8 | Nanchang Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 2026 Chinese Pharmaceutical Association Medicinal Chemistry Symposium (CMCS2026) in Nanchang. (IMAGE)

InSilico Medicine

November 6–8 | Nanchang Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 2026 Chinese Pharmaceutical Association Medicinal Chemistry Symposium (CMCS2026) in Nanchang.

Caption

On the morning of November 7 at 11:00 AM, he will deliver a presentation titled: "Generative AI-Driven Innovative Drug Discovery and Clinical Advances."

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.